Assessment of cardiovascular risk in paediatric peritoneal dialysis patients: A Turkish Pediatric Peritoneal Dialysis Study Group (TUPEPD) report

Nephrology Dialysis Transplantation

Volumn 24, Issue 11, 2009, Pages 3525-3532

  Bakkaloglu, Sevcan A ^a   Saygili, Arda ^b   Sever, Lale ^c   Noyan, Aytul ^d   Akman, Sema ^e   Ekim, Mesiha ^f   Aksu, Nejat ^g   Doganay, Beyza ^f   Yildiz, Nurdan ^h   Duzova, Ali ⁱ   Soylu, Alper ^j   Alpay, Harika ^k   Sonmez, Ferah ^l   Civilibal, Mahmut ^c   Erdem, Sevcan ^d   Kardelen, Firat ^e  

^a GAZI UNIVERSITY   (Turkey)

^b ACIBADEM UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d CUKUROVA UNIVERSITY   (Turkey)

^e AKDENIZ UNIVERSITY   (Turkey)

^f ANKARA UNIVERSITY   (Turkey)

^g Tepecik Teaching Hospital   (Turkey)

^h Health Ministry Goztepe Education and Research Hospital   (Turkey)

ⁱ HACETTEPE UNIVERSITY   (Turkey)

^j DOKUZ EYLUL UNIVERSITY   (Turkey)

^k MARMARA UNIVERSITY   (Turkey)

^l ADNAN MENDERES UNIVERSITY   (Turkey)

more..

Author keywords

Cardiovascular disease; Children; Chronic kidney disease; Echocardiography; Peritoneal dialysis

Indexed keywords

APOLIPOPROTEIN B; C REACTIVE PROTEIN; HEMOGLOBIN; HIGH SENSITIVITY C REACTIVE PROTEIN; HOMOCYSTEINE; LIPOPROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTERIAL WALL THICKNESS; ARTERIOSCLEROSIS; ARTICLE; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CHILD; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART PERFORMANCE; HUMAN; KIDNEY FAILURE; LIPID BLOOD LEVEL; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; TISSUE DOPPLER IMAGING; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CHRONIC KIDNEY FAILURE; ECHOCARDIOGRAPHY; HEART MUSCLE; PATHOLOGY; RISK FACTOR;

ADOLESCENT; ADULT; BLOOD PRESSURE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CHILD; ECHOCARDIOGRAPHY; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MYOCARDIUM; PERITONEAL DIALYSIS; RISK FACTORS; YOUNG ADULT;

EID: 73949112080     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp297     Document Type: Article

References (63)

1. Mitsnefes MM. CV complications of pediatric chronic kidney disease. Pediatr Nephrol 2008; 23: 27-39
2. Groothoff JW, Gruppen MP, Offringa M, et al. Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study. Kidney Int 2002; 61: 621-629
3. Parekh RS, Carrol CE, Wolfe RA, et al. CV mortality in children and young adults with end-stage kidney disease. J Pediatr 2002; 141: 191-197
4. Chavers BM, Li S, Collins AJ, et al. CV disease in pediatric chronic dialysis patients. Kidney Int 2002; 62: 648-653
5. North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS). Annual Report 2008 https://web. emmes. com/study/ped/ annlrept
6. United States Renal Data System. 2007. Annual Report. http://www. usrds. org/adr-2007. htm
7. Kari JA, Donald AE, Vallance DT, et al. Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int 1997; 52: 468-472
8. Mitsnefes MM. Pediatric end-stage renal disease: heart as a target. J Pediatr 2002; 141: 162-164
9. Litwin M, Trelewicz J, Wawer Z, et al. Intima-media thickness and arterial elasticity in hypertensive children: controlled study. Pediatr Nephrol 2004; 19: 767-774
10. Oh J, Wunsch R, Turzer M, et al. Advanced coronary and carotid ar-teriopathy in young adults with childhood-onset chronic renal failure. Circulation 2002; 106: 100-105
11. Nascimento MM, Pecoits-Filho R, Qureshi AR, et al. The prognostic impact of fluctuating levels of C-reactive protein in Brazilian haemodialysis patients: a prospective study. Nephrol Dial Transplant 2004; 19: 2803-2809
12. Stenvinkel P, Barany P, Heimbürger O, et al. Mortality, malnutrition, and atherosclerosis in ESRD: what is the role of interleukin-6? Kidney Int 2002; (Suppl 80): S103-S108
13. Sylvestre LC, Fonseca KPD, Stinghen AEM, et al. The malnutrition and inflammation axis in pediatric patients with chronic kidney disease. Pediatr Nephrol 2007; 22: 864-873
14. Bakkaloglu SA, Buyan N, Funahashi T, et al. Adiponectin levels and atherosclerotic risk factors in pediatric chronic peritoneal dialysis patients. Perit Dial Int. 2005; 25: 357-361
15. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and CV disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511
16. Civilibal M, Caliskan S, Oflaz H, et al. Traditional and 'new' CV risk markers and factors in pediatric dialysis patients. Pediatr Nephrol 2007; 22: 1021-1029
17. Atalay S, Ekim M, Tutar HE, et al. Systolic and diastolic function in children with chronic renal failure. Pediatr Int 2002; 44: 18-23
18. Bakkalog?lu SA, Ekim M, Koçak G, et al. Impact of dialysis adequacy on cardiac function in pediatric CAPD patients. Perit Dial Int. 2001; 21: 395-400
19. Saygili A, Yildirim SV, Cengiz N, et al. Assessment of left ventricular diastolic function by Doppler tissue imaging in children with end-stage renal disease. Acta Paediatr 2005; 94: 1055-1059
20. Uçar T, Tutar E, Yalçinkaya F, et al. Global left-ventricular function by tissue Doppler imaging in pediatric dialysis patients. Pediatr Nephrol 2008; 23: 779-785
21. Bakkaloglu SA, Ekim M, Sever L, et al. Chronic peritoneal dialysis in Turkish children: a multicenter study. Pediatr Nephrol 2005; 20: 644-651
22. Tumer N, Yalcinkaya F, Ince E, et al. BP nomograms for children and adolescents in Turkey. Pediatr Nephrol 1999; 13: 438-443
23. Chavers BM, Li S, Collins AJ, et al. Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int 2002; 62: 648-653
24. Horl WH. Atherosclerosis and uremia: significance of non-traditional risk factors. Wien Klin Wochenschr 2003; 115: 220-234
25. Llopart R, Doñate T, Oliva JA, et al. Triglyceride-rich lipoprotein abnormalities in CAPD-treated patients. Nephrol Dial Transplant 1995; 10: 537-540
26. Bakkaloglu SA, Ekim M, Tümer N, et al. The effect of CAPD on lipid profile of pediatric patients. Perit Dial Int 2000; 20: 568-571
27. Penisi AJ, Heuser ET, Mickey MR, et al. Hyperlipidemia in pediatric hemodialysis and renal transplant patients. Associated with coronary artery disease. Am J Dis Child 1976; 130: 957-961
28. Roh EJ, Lim JW, Ko KO, et al. A useful predictor of early atherosclerosis in obese children: serum high-sensitivity C-reactive protein. J Korean Med Sci 2007; 22: 192-197
29. Kavey RE, Allada V, Daniels SR, et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High BP Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 2006; 114: 2710-2738
30. Pecoits-Filho R, Heimburger O, Barany P, et al. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis 2003; 41: 1212-1218
31. Goldstein SL, Currier H, Watters L, et al. Acute and chronic inflammation in pediatric patients receiving hemodialysis. J Pediatr 2003; 143: 653-657
32. Paraskevas KI. Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering. Int Urol Nephrol 2008; 40: 165-170
33. Ikejiri A, Hirano T, Murayama S, et al. Effects of atorvastatin on triglyceride-rich lipoproteins, low-density lipoprotein subclass, and C-reactive protein in hemodialysis patients. Metabolism 2004; 53: 1113-1117
34. Shantouf R, Budoff MJ, Ahmadi N, et al. Effects of sevelamer and calcium-based phosphate binders on lipid and inflammatory markers in hemodialysis patients. Am J Nephrol 2008; 28: 275-279
35. Takei T, Otsubo S, Uchida K, et al. Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis. Nephron Clin Pract 2008; 108: c278-c283
36. Mitsnefes MM, Kimball TR, Kartal J, et al. Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: role of calcium-phosphorus metabolism. J Am Soc Nephrol 2005; 16: 2796-2803
37. Litwin M, Wühl E, Jourdan C, et al. Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 2005; 16: 1494-1500
38. Spiegel DM, Raggi P, Smits G, et al. Factors associated with mortality in patients new to haemodialysis. Nephrol Dial Transplant 2007; 22: 3568-3572
39. Akdag I, Yilmaz Y, Kahvecioglu S, et al. Clinical value of the malnutrition-inflammation-atherosclerosis syndrome for long-term prediction of cardiovascular mortality in patients with end-stage renal disease: a 5-year prospective study. Nephron Clin Pract 2008; 108: c99-c105
40. Litwin M, Wühl E, Jourdan C, et al. Evolution of large-vessel arte-riopathy in paediatric patients with chronic kidney disease. Nephrol Dial Transplant 2008; 23: 2552-2557
41. Poyrazoglu HM, Dusunsel R, Yikilmaz A, et al. Carotid artery thickness in children and young adults with end stage renal disease. Pediatr Nephrol 2007; 22: 109-116
42. Matteucci MC, Wühl E, Picca S, et al. Left ventricular geometry in children with mild to moderate chronic renal insufficiency. J Am Soc Nephrol 2006; 17: 218-226
43. Roman MJ, Saba PS, Pini R, et al. Parallel cardiac and vascular adaptation in hypertension. Circulation 1992; 86: 1909-1918
44. Nitta K, Akiba T, Uchida K, et al. Left ventricular hypertrophy is associated with arterial stiffness and vascular calcification in hemodialysis patients. Hypertens Res 2004; 27: 47-52
45. Chinali M, de Simone G, Matteucci MC, et al. Reduced systolic my-ocardial function in children with chronic renal insufficiency. J Am Soc Nephrol 2007; 18: 593-598
46. Ulinski T, Genty J, Viau C, et al. Reduction of left ventricular hypertrophy in children undergoing hemodialysis. Pediatr Nephrol 2006; 21: 1171-1178
47. Mitsnefes MM, Barletta GM, Dresner IG, et al. Severe cardiac hypertrophy and long-term dialysis: the Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol 2006; 21: 1167-1170
48. Sohn DW, Chai IH, Lee DJ, et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997; 30: 474-480
49. GorcsanJ. Tissue Doppler echocardiography. Curr Opin Cardiol2000; 15: 323-329
50. Ie EH, Vletter WB, ten Cate FJ, et al. Preload dependence of new Doppler techniques limits their utility for left ventricular diastolic function assessment in hemodialysis patients. J Am Soc Nephrol 2003; 14: 1858-1862
51. Lee TY, Kang PL, Hsiao SH, et al. Tissue Doppler velocity is not totally preload-independent: a study in a uremic population after hemodialy-sis. Cardiology 2007; 107: 415-421
52. Lubanda JC, Palecek T, Trckova R, et al. Preload dependence of the time interval between onsets of mitral inflow and early diastolic mitral annular velocity: a study in healthy subjects. Echocardiography 2008; 25: 249-255
53. Wang AY, Wang M, Woo J, et al. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. J Am Soc Nephrol 2004; 15: 2186-2194
54. Liao CT, Chen YM, Shiao CC, et al. Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis. Nephrol Dial Transplant 2009; 24: 2909-2914
55. Tam P. Peritoneal dialysis and preservation of residual renal function. Perit Dial Int 2009; 29: S108-S110
56. Ates K, Ates A, Ekmekci Y, et al. The time course of serum C-reactive protein is more predictive of mortality than its baseline level in peritoneal dialysis patients. Perit Dial Int 2005; 25: 256-268
57. Bakkaloglu SA, Soylemezoglu O, Buyan N, et al. Adiponectin levels and arteriosclerotic risk factors in pediatric renal transplant recipients. Pediatr Transplant 2006; 10: 187-192
58. Reichek N, Wilson J, St John Sutton M, et al. Noninvasive determination of left ventricular end-systolic stress: validation of the method and initial application. Circulation 1982; 65: 99-108
59. Devereux RB, Reichec N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977; 55: 613-618
60. De Simone G, Daniels SR, Devereux RB, et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 1992; 20: 1251-1260
61. De Simone G, Devereux RB, Daniels SR, et al. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict CV risk. J Am Coll Cardiol 1995; 25: 1056-1062
62. Daniels SR, Loggie JMH, Khoury P, et al. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation 1998; 97: 1907-1911
63. Tei C, Ling LH, Hodge DO, et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function-a study in normals and dilated cardiomyopathy. J Cardiol 1995; 26: 357-366